Edwards Lifesciences (NYSE: EW) grants 3,251 RSUs to director

Edwards Lifesciences director Leslie Stone Heisz was granted 3,251 restricted stock units (RSUs) on May 8, 2026, under the company’s 2020 Nonemployee Directors Stock Incentive Program. These RSUs will vest 100% after one year from the grant date or the next annual stockholders’ meeting, adding to her direct holdings of 34,199 shares of common stock. The grant price per share was $0.00, indicating it was a compensation award rather than a purchase.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin